Overall Fundamental outlook

Business Operations:

Sector: Consumer Defensive
Industry: Household & Personal Products

Emami Limited manufactures and markets personal and healthcare products in India and internationally. It provides ayurvedic antiseptic cream, prickly heat powder, doodh kesar body lotion, aloe neem lotion, vasocare herbal petroleum jelly, coconut oil, aloe vera gel, and hygiene products under the Boroplus brand; cool oil, extra thanda, gold ayurvedic oil, therapy ayurvedic body massage and stress relief oil, maxx cool talc, and cool talc under the Navratna brand; and balm, balm ultra-power, quick relief roll-on, ortho vedic oil, ointment, relief gel and spray, healthcare products, pancharishta, nityam, and kesari jivan under the Zandu brand. The company also offers radiance cream and instant radiance face wash for men under the Fair and Handsome brand; haircare products and shampoo under the Kesh King brand; balm under the Mentho Plus brand; prickly heat powder under the Dermicool brand; hair oil, shampoos, and conditioners under the Emami 7 Oils in One brand; deodorants under the HE brand; hair colors under the Emami Diamond Shine brand; talc under the Emami Golden Beauty brand; herbal fairness cream under the Emami Naturally Fair brand; toothpaste under the Ayucare brand; hair colors and oils under the Emami Gold brand; and moisturisers, lotion, soft creams, glycerine creams and oils, petroleum jelly, baby shampoos, and other skin products under the Cream21 brand. Emami Limited was founded in 1974 and is headquartered in Kolkata, India.

Revenue projections:

Revenue projections for EMAMILTD
Revenue projections for EMAMILTD

EMAMILTD is projected to see lower revenues than in the previous year, a trend that usually concerns investors. Declining revenues often harm a company's profitability, leading investors to exercise caution as they weigh the potential risks of continued financial downturns.

Financial Ratios:

currentRatio 0.000000
forwardPE 23.929907
debtToEquity 3.333000
earningsGrowth 0.074000
revenueGrowth -0.002000
grossMargins 0.690660
operatingMargins 0.187720
trailingEps 18.730000
forwardEps 0.000000

EMAMILTD's Forward PE ratio is favorable, meaning the stock price aligns well with earnings and isn't overvalued. This allows room for growth, making it an attractive investment for those seeking potential upside while ensuring the stock is not overpriced.
EMAMILTD's low earnings and revenue growth suggest that the company's profits may shrink. This trend could indicate underlying financial struggles and pose challenges for EMAMILTD's future profitability.
EMAMILTD's negative gross and operating margins indicate that the company is currently unprofitable at both the production and operational levels. This suggests significant challenges in managing costs and generating revenue, which could impact its overall financial health.

Price projections:

Price projections for EMAMILTD
Price projections for EMAMILTD

EMAMILTD's price projections have gradually decreased, reflecting a less optimistic view of the company's future performance. Analysts are adjusting their expectations, suggesting potential concerns about EMAMILTD's ability to meet previous growth targets.

Recommendation changes over time:

Recommendations trend for EMAMILTD
Recommendations trend for EMAMILTD


Analysts have maintained a buy bias for EMAMILTD, which could prompt investors to consider the stock as a viable investment. With this positive outlook, EMAMILTD is positioned as an attractive option for those looking to park their money in a stable and potentially lucrative company.